Furthermore, METTL3-mediated activation of the TRAF6/NF-κB pathway via m6A promotes neuroinflammation in microglia, highlighting a novel target for therapeutic strategies in AD [36,37,38,39] (Figure 2). The gene discussed is METTL3; the disease is Alzheimer disease.